Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 190Thoracic 6Genitourinary 4Dermatologic 4Plasma cell 3Other hematologic neoplasm 3Breast 3Sarcoma 2Lymphoid 2Gynecologic 2CNS 2Myeloid 1Head & Neck 1Classical hematology 1

Conditions

Sarcoma 6Colorectal Neoplasms 6Neoplasm Metastasis 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Chondrosarcoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Carcinoma 2Urinary Bladder Neoplasms 1Tracheal Neoplasms 1Thyroid Neoplasms 1Solitary Pulmonary Nodule 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Pulmonary Sclerosing Hemangioma 1Prostatic Neoplasms 1Phyllodes Tumor 1Parathyroid Neoplasms 1Pancoast Syndrome 1Ovarian Neoplasms 1Otorhinolaryngologic Neoplasms 1Osteosarcoma 1Myxosarcoma 1Myosarcoma 1

Interventions

Gemcitabine 9pembrolizumab 7Irinotecan 5Docetaxel 4Cisplatin 4Carboplatin 4Capecitabine 4Albumin-Bound Paclitaxel 4Paclitaxel 3Oxaliplatin 3Leucovorin 3Cyclophosphamide 3Cetuximab 3130-nm albumin-bound paclitaxel 3pazopanib 2palbociclib 2liposomal doxorubicin 2entrectinib 2alectinib 2Vinorelbine 2Trastuzumab 2Taxes 2Radiosurgery 2Oncolytic Virotherapy 2Observation 2Ipilimumab 2Fluorouracil 2Fluorodeoxyglucose F18 2Filgrastim 2Erlotinib Hydrochloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Fluorouracil × Sarcoma × Clear all
NCT02574663 2019-10-02

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

TG Therapeutics, Inc.

Phase 1 Completed
66 enrolled
GastrointestinalSarcoma

Esophageal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT00654160 2017-05-25

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Mayo Clinic

Phase 1 Completed
7 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡